Keith S Manchester's Net Worth
$1.34 Billion
Who is Keith S Manchester?
Keith S Manchester has an estimated net worth of $1.34 Billion. This is based on reported shares across multiple companies, which include APPLIED MOLECULAR EVOLUTION INC, Arbutus Biopharma Corp, Myovant Sciences Ltd., and Roivant Sciences Ltd..
SEC CIK
Keith S Manchester's CIK is 0001244828
Past Insider Trading and Trends
2004 was Keith S Manchester's most active year for acquiring shares with 5 total transactions. Keith S Manchester's most active month to acquire stocks was the month of January. 2022 was Keith S Manchester's most active year for disposing of shares, totalling 5 transactions. Keith S Manchester's most active month to dispose stocks was the month of October. 2004 saw Keith S Manchester paying a total of $225,920.70 for 40,523 shares, this is the most they've acquired in one year. In 2023 Keith S Manchester cashed out on 6,896,144 shares for a total of $79,650,463.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
APPLIED MOLECULAR EVOLUTION INC No price found
VP, BUSINESS DEVELOPMENT
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.85% | 30.21K |
$6.88 | $207,981.30 | 371.54K |
Feb 9
| |||
Form 4
| +3.11% | 10.31K |
$1.74 | $17,939.40 | 341.32K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arbutus Biopharma Corp (ABUS) Snapshot price: $2.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Myovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Roivant Sciences Ltd. (ROIV) Snapshot price: $10.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -38.99% | -30.26M |
—
|
—
| 47.35M |
Mar 7
| |||
Form 4
| -8.16% | -6.90M |
$11.55 | -$79,650,463.20 | 77.61M |
Sep 28
| |||
Form 4
| +34.19% | 17.82K |
—
|
—
| 69.97K |
Sep 12
| |||
Form 4
| -5.71% | -5.12M |
$4.75 | -$13,443,207.75 | 84.51M |
Nov 9 - Nov 10
| |||
Form 4
|
∞
| 52.14K |
—
|
—
| 52.14K |
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||